Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
Abstract Respiratory syncytial virus (RSV) infection is a common cause of hospitalisation in infants and the elderly. Palivizumab prophylaxis is the only approved treatment modality but is costly and only offered to select vulnerable populations. Here, we investigated gene delivery approaches via re...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/02a847cbdd3747d0b7746de8f6676a1b |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|